nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—SLC22A8—choroid plexus—intracranial aneurysm	0.194	0.212	CbGeAlD
Indomethacin—PTGDR2—cerebellum—intracranial aneurysm	0.043	0.047	CbGeAlD
Indomethacin—PTGR2—medulla oblongata—intracranial aneurysm	0.0404	0.0442	CbGeAlD
Indomethacin—PPARG—artery—intracranial aneurysm	0.0402	0.0439	CbGeAlD
Indomethacin—PTGR2—midbrain—intracranial aneurysm	0.0369	0.0404	CbGeAlD
Indomethacin—PTGDR2—brain—intracranial aneurysm	0.035	0.0382	CbGeAlD
Indomethacin—PTGR2—cerebellum—intracranial aneurysm	0.0286	0.0312	CbGeAlD
Indomethacin—GLO1—medulla oblongata—intracranial aneurysm	0.025	0.0273	CbGeAlD
Indomethacin—PTGR2—brain—intracranial aneurysm	0.0232	0.0254	CbGeAlD
Indomethacin—CXCL8—medulla oblongata—intracranial aneurysm	0.023	0.0251	CbGeAlD
Indomethacin—GLO1—midbrain—intracranial aneurysm	0.0228	0.0249	CbGeAlD
Indomethacin—PTGS1—artery—intracranial aneurysm	0.0215	0.0235	CbGeAlD
Indomethacin—PLA2G2A—midbrain—intracranial aneurysm	0.0212	0.0232	CbGeAlD
Indomethacin—CXCL8—midbrain—intracranial aneurysm	0.021	0.023	CbGeAlD
Indomethacin—PTGS2—artery—intracranial aneurysm	0.0205	0.0224	CbGeAlD
Indomethacin—AKR1C3—medulla oblongata—intracranial aneurysm	0.018	0.0197	CbGeAlD
Indomethacin—GLO1—cerebellum—intracranial aneurysm	0.0177	0.0193	CbGeAlD
Indomethacin—AKR1C3—midbrain—intracranial aneurysm	0.0165	0.018	CbGeAlD
Indomethacin—CXCL8—cerebellum—intracranial aneurysm	0.0162	0.0178	CbGeAlD
Indomethacin—PPARA—cerebellum—intracranial aneurysm	0.0153	0.0168	CbGeAlD
Indomethacin—GLO1—brain—intracranial aneurysm	0.0143	0.0157	CbGeAlD
Indomethacin—PLA2G2A—brain—intracranial aneurysm	0.0133	0.0146	CbGeAlD
Indomethacin—CXCL8—brain—intracranial aneurysm	0.0132	0.0144	CbGeAlD
Indomethacin—AKR1C3—cerebellum—intracranial aneurysm	0.0127	0.0139	CbGeAlD
Indomethacin—PPARA—brain—intracranial aneurysm	0.0125	0.0136	CbGeAlD
Indomethacin—SLC10A1—brain—intracranial aneurysm	0.012	0.0131	CbGeAlD
Indomethacin—SLCO1A2—medulla oblongata—intracranial aneurysm	0.0112	0.0123	CbGeAlD
Indomethacin—SLC22A7—brain—intracranial aneurysm	0.0107	0.0117	CbGeAlD
Indomethacin—AKR1C3—brain—intracranial aneurysm	0.0103	0.0113	CbGeAlD
Indomethacin—SLC22A6—brain—intracranial aneurysm	0.0103	0.0113	CbGeAlD
Indomethacin—SLCO1A2—midbrain—intracranial aneurysm	0.0103	0.0112	CbGeAlD
Indomethacin—CES1—brain—intracranial aneurysm	0.00924	0.0101	CbGeAlD
Indomethacin—SLCO1A2—cerebellum—intracranial aneurysm	0.00795	0.00869	CbGeAlD
Indomethacin—ABCC3—brain—intracranial aneurysm	0.00753	0.00823	CbGeAlD
Indomethacin—PPARG—brain—intracranial aneurysm	0.00685	0.00748	CbGeAlD
Indomethacin—ABCC1—cerebellum—intracranial aneurysm	0.00653	0.00713	CbGeAlD
Indomethacin—SLCO1A2—brain—intracranial aneurysm	0.00646	0.00706	CbGeAlD
Indomethacin—ALB—brain—intracranial aneurysm	0.00642	0.00702	CbGeAlD
Indomethacin—ABCC4—brain—intracranial aneurysm	0.00622	0.00679	CbGeAlD
Indomethacin—SLC22A8—brain—intracranial aneurysm	0.00617	0.00674	CbGeAlD
Indomethacin—PTGS2—medulla oblongata—intracranial aneurysm	0.00609	0.00666	CbGeAlD
Indomethacin—PTGS2—midbrain—intracranial aneurysm	0.00557	0.00609	CbGeAlD
Indomethacin—ABCC1—brain—intracranial aneurysm	0.0053	0.00579	CbGeAlD
Indomethacin—CES1—E2F transcription factor network—RBBP8—intracranial aneurysm	0.00481	0.0566	CbGpPWpGaD
Indomethacin—PTGS2—cerebellum—intracranial aneurysm	0.00431	0.00471	CbGeAlD
Indomethacin—ABCB1—medulla oblongata—intracranial aneurysm	0.00377	0.00412	CbGeAlD
Indomethacin—PTGS1—brain—intracranial aneurysm	0.00366	0.004	CbGeAlD
Indomethacin—PTGS2—brain—intracranial aneurysm	0.0035	0.00382	CbGeAlD
Indomethacin—ABCB1—midbrain—intracranial aneurysm	0.00344	0.00376	CbGeAlD
Indomethacin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—SLC25A16—intracranial aneurysm	0.003	0.0353	CbGpPWpGaD
Indomethacin—ABCB1—cerebellum—intracranial aneurysm	0.00266	0.00291	CbGeAlD
Indomethacin—ABCB1—brain—intracranial aneurysm	0.00216	0.00237	CbGeAlD
Indomethacin—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC25A16—intracranial aneurysm	0.00201	0.0237	CbGpPWpGaD
Indomethacin—CXCL8—ATF4 activates genes—CCL2—intracranial aneurysm	0.00193	0.0227	CbGpPWpGaD
Indomethacin—PTGS1—Prostaglandin Synthesis and Regulation—EDNRA—intracranial aneurysm	0.00187	0.022	CbGpPWpGaD
Indomethacin—CXCL8—PERK regulates gene expression—CCL2—intracranial aneurysm	0.00176	0.0208	CbGpPWpGaD
Indomethacin—CXCL8—AP-1 transcription factor network—TIMP1—intracranial aneurysm	0.00168	0.0197	CbGpPWpGaD
Indomethacin—PTGDR2—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.00156	0.0183	CbGpPWpGaD
Indomethacin—PTGS2—Prostaglandin Synthesis and Regulation—EDNRA—intracranial aneurysm	0.00148	0.0175	CbGpPWpGaD
Indomethacin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—intracranial aneurysm	0.00141	0.0166	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—STARD13—intracranial aneurysm	0.00141	0.0166	CbGpPWpGaD
Indomethacin—CXCL8—Syndecan-2-mediated signaling events—MMP2—intracranial aneurysm	0.00137	0.0162	CbGpPWpGaD
Indomethacin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—intracranial aneurysm	0.00134	0.0158	CbGpPWpGaD
Indomethacin—PTGDR2—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.00133	0.0157	CbGpPWpGaD
Indomethacin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—intracranial aneurysm	0.00126	0.0148	CbGpPWpGaD
Indomethacin—ABCC4—Platelet degranulation—TIMP1—intracranial aneurysm	0.00118	0.0139	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00117	0.0138	CbGpPWpGaD
Indomethacin—ABCC4—Response to elevated platelet cytosolic Ca2+—TIMP1—intracranial aneurysm	0.00112	0.0132	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR ligand binding—EDNRA—intracranial aneurysm	0.00101	0.0119	CbGpPWpGaD
Indomethacin—CXCL8—Chemokine receptors bind chemokines—CCL2—intracranial aneurysm	0.00101	0.0119	CbGpPWpGaD
Indomethacin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—intracranial aneurysm	0.00101	0.0119	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000999	0.0117	CbGpPWpGaD
Indomethacin—PPARA—Circadian rythm related genes—CST3—intracranial aneurysm	0.00099	0.0117	CbGpPWpGaD
Indomethacin—PLA2G2A—Spinal Cord Injury—CCL2—intracranial aneurysm	0.000968	0.0114	CbGpPWpGaD
Indomethacin—CES1—NRF2 pathway—AGER—intracranial aneurysm	0.000952	0.0112	CbGpPWpGaD
Indomethacin—CXCL8—ATF-2 transcription factor network—MMP2—intracranial aneurysm	0.000925	0.0109	CbGpPWpGaD
Indomethacin—CXCL8—LPA receptor mediated events—MMP2—intracranial aneurysm	0.000866	0.0102	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000859	0.0101	CbGpPWpGaD
Indomethacin—CXCL8—AP-1 transcription factor network—CCL2—intracranial aneurysm	0.000848	0.00997	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—SLC25A16—intracranial aneurysm	0.00079	0.00929	CbGpPWpGaD
Indomethacin—CXCL8—Unfolded Protein Response (UPR)—CCL2—intracranial aneurysm	0.000777	0.00915	CbGpPWpGaD
Indomethacin—CXCL8—Peptide ligand-binding receptors—EDNRA—intracranial aneurysm	0.000774	0.00911	CbGpPWpGaD
Indomethacin—PPARA—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000745	0.00876	CbGpPWpGaD
Indomethacin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—intracranial aneurysm	0.000725	0.00853	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—CST3—intracranial aneurysm	0.00071	0.00835	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—STARD13—intracranial aneurysm	0.000696	0.00819	CbGpPWpGaD
Indomethacin—PLA2G2A—Spinal Cord Injury—MMP9—intracranial aneurysm	0.000692	0.00814	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—SLC25A16—intracranial aneurysm	0.000689	0.00811	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—SLC25A16—intracranial aneurysm	0.000671	0.0079	CbGpPWpGaD
Indomethacin—PTGDR2—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000657	0.00772	CbGpPWpGaD
Indomethacin—CXCL8—LPA receptor mediated events—MMP9—intracranial aneurysm	0.000651	0.00766	CbGpPWpGaD
Indomethacin—CXCL8—Corticotropin-releasing hormone—NOS3—intracranial aneurysm	0.000607	0.00714	CbGpPWpGaD
Indomethacin—CXCL8—AP-1 transcription factor network—MMP9—intracranial aneurysm	0.000606	0.00713	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—SLC25A16—intracranial aneurysm	0.000577	0.00679	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000573	0.00675	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000564	0.00664	CbGpPWpGaD
Indomethacin—CXCL8—Spinal Cord Injury—CCL2—intracranial aneurysm	0.000558	0.00657	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—STARD13—intracranial aneurysm	0.000549	0.00646	CbGpPWpGaD
Indomethacin—UGT2B7—NRF2 pathway—AGER—intracranial aneurysm	0.000547	0.00643	CbGpPWpGaD
Indomethacin—ABCC3—NRF2 pathway—AGER—intracranial aneurysm	0.000547	0.00643	CbGpPWpGaD
Indomethacin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—intracranial aneurysm	0.000545	0.00641	CbGpPWpGaD
Indomethacin—ALB—Platelet degranulation—TIMP1—intracranial aneurysm	0.000534	0.00628	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000534	0.00628	CbGpPWpGaD
Indomethacin—ABCC4—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.000523	0.00616	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—ASAH1—intracranial aneurysm	0.000523	0.00615	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000521	0.00613	CbGpPWpGaD
Indomethacin—CXCL8—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.000519	0.00611	CbGpPWpGaD
Indomethacin—ABCC4—NRF2 pathway—AGER—intracranial aneurysm	0.000514	0.00605	CbGpPWpGaD
Indomethacin—ALB—Response to elevated platelet cytosolic Ca2+—TIMP1—intracranial aneurysm	0.000509	0.00598	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—SLC25A16—intracranial aneurysm	0.000501	0.00589	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR ligand binding—CCL2—intracranial aneurysm	0.0005	0.00588	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000491	0.00578	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000459	0.00539	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—ASAH1—intracranial aneurysm	0.000445	0.00523	CbGpPWpGaD
Indomethacin—UGT1A1—NRF2 pathway—AGER—intracranial aneurysm	0.000444	0.00523	CbGpPWpGaD
Indomethacin—UGT1A9—NRF2 pathway—AGER—intracranial aneurysm	0.000444	0.00523	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000442	0.0052	CbGpPWpGaD
Indomethacin—ABCC2—NRF2 pathway—AGER—intracranial aneurysm	0.000434	0.0051	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00042	0.00494	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.000411	0.00484	CbGpPWpGaD
Indomethacin—CXCL8—Spinal Cord Injury—MMP9—intracranial aneurysm	0.000399	0.0047	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000395	0.00465	CbGpPWpGaD
Indomethacin—PTGS1—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.00039	0.00458	CbGpPWpGaD
Indomethacin—ALB—Vitamin B12 Metabolism—CCL2—intracranial aneurysm	0.000387	0.00455	CbGpPWpGaD
Indomethacin—ABCC4—Ectoderm Differentiation—CCL2—intracranial aneurysm	0.000386	0.00454	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—ASAH1—intracranial aneurysm	0.000382	0.0045	CbGpPWpGaD
Indomethacin—CXCL8—Peptide ligand-binding receptors—CCL2—intracranial aneurysm	0.000381	0.00449	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—SLC25A16—intracranial aneurysm	0.000379	0.00446	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—SLC25A16—intracranial aneurysm	0.000379	0.00446	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000374	0.0044	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—SLC25A16—intracranial aneurysm	0.000359	0.00422	CbGpPWpGaD
Indomethacin—ABCC1—Disease—SLC25A16—intracranial aneurysm	0.000355	0.00418	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—ASAH1—intracranial aneurysm	0.000332	0.0039	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—SLC25A16—intracranial aneurysm	0.00033	0.00389	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—NCF1—intracranial aneurysm	0.000326	0.00383	CbGpPWpGaD
Indomethacin—ALB—Folate Metabolism—CCL2—intracranial aneurysm	0.000315	0.00371	CbGpPWpGaD
Indomethacin—PTGS2—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.000309	0.00364	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—SLC25A16—intracranial aneurysm	0.000308	0.00363	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—SLC25A16—intracranial aneurysm	0.000308	0.00363	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—EDNRA—intracranial aneurysm	0.000308	0.00362	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—SLC25A16—intracranial aneurysm	0.000297	0.0035	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000297	0.00349	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.000291	0.00343	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—SLC25A16—intracranial aneurysm	0.000282	0.00332	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—TIMP1—intracranial aneurysm	0.00027	0.00317	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—CST3—intracranial aneurysm	0.000264	0.00311	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—CCL2—intracranial aneurysm	0.000257	0.00302	CbGpPWpGaD
Indomethacin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000256	0.00301	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—SLC25A16—intracranial aneurysm	0.000251	0.00296	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—ASAH1—intracranial aneurysm	0.000251	0.00296	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—ASAH1—intracranial aneurysm	0.000251	0.00296	CbGpPWpGaD
Indomethacin—ALB—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.00025	0.00294	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—CCL2—intracranial aneurysm	0.000245	0.00288	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00024	0.00282	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SLC25A16—intracranial aneurysm	0.000238	0.0028	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—ASAH1—intracranial aneurysm	0.000238	0.0028	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.000237	0.00279	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—NCF1—intracranial aneurysm	0.00023	0.0027	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000223	0.00263	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—ASAH1—intracranial aneurysm	0.000219	0.00257	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000216	0.00254	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—ASAH1—intracranial aneurysm	0.000204	0.0024	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—ASAH1—intracranial aneurysm	0.000204	0.0024	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000203	0.00239	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—SLC25A16—intracranial aneurysm	0.000199	0.00235	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ASAH1—intracranial aneurysm	0.000197	0.00232	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000197	0.00231	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—CCL2—intracranial aneurysm	0.000195	0.00229	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ASAH1—intracranial aneurysm	0.000187	0.0022	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—MMP2—intracranial aneurysm	0.000186	0.00218	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—MMP9—intracranial aneurysm	0.000175	0.00206	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ASAH1—intracranial aneurysm	0.000166	0.00196	CbGpPWpGaD
Indomethacin—ALB—Metabolism—SLC25A16—intracranial aneurysm	0.000161	0.0019	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—NCF1—intracranial aneurysm	0.000161	0.00189	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—EDNRA—intracranial aneurysm	0.000152	0.00179	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—CCL2—intracranial aneurysm	0.000152	0.00178	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—SLC25A16—intracranial aneurysm	0.000145	0.0017	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SLC25A16—intracranial aneurysm	0.000141	0.00166	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—MMP9—intracranial aneurysm	0.00014	0.00164	CbGpPWpGaD
Indomethacin—CXCL8—Metabolism of proteins—CCL2—intracranial aneurysm	0.000137	0.00161	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CST3—intracranial aneurysm	0.000136	0.0016	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—NOS3—intracranial aneurysm	0.000135	0.00159	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—MMP2—intracranial aneurysm	0.000133	0.00157	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ASAH1—intracranial aneurysm	0.000132	0.00155	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SLC25A16—intracranial aneurysm	0.000132	0.00155	CbGpPWpGaD
Indomethacin—CXCL8—Metabolism of proteins—MMP2—intracranial aneurysm	0.00013	0.00153	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NCF1—intracranial aneurysm	0.000127	0.00149	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TIMP1—intracranial aneurysm	0.000122	0.00144	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—NOS3—intracranial aneurysm	0.000122	0.00143	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EDNRA—intracranial aneurysm	0.00012	0.00141	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NCF1—intracranial aneurysm	0.000118	0.00139	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—NOS3—intracranial aneurysm	0.000109	0.00128	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—MMP9—intracranial aneurysm	0.000108	0.00128	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ASAH1—intracranial aneurysm	0.000107	0.00126	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—MMP9—intracranial aneurysm	0.0001	0.00118	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—CCL2—intracranial aneurysm	0.0001	0.00118	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ASAH1—intracranial aneurysm	9.6e-05	0.00113	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—NOS3—intracranial aneurysm	9.53e-05	0.00112	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ASAH1—intracranial aneurysm	9.37e-05	0.0011	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—NOS3—intracranial aneurysm	9.28e-05	0.00109	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CST3—intracranial aneurysm	9.13e-05	0.00107	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ASAH1—intracranial aneurysm	8.75e-05	0.00103	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—NOS3—intracranial aneurysm	7.98e-05	0.000939	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NCF1—intracranial aneurysm	7.94e-05	0.000934	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CCL2—intracranial aneurysm	7.49e-05	0.000881	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—NOS3—intracranial aneurysm	6.92e-05	0.000814	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—NOS3—intracranial aneurysm	6.67e-05	0.000785	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCL2—intracranial aneurysm	5.91e-05	0.000695	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—NOS3—intracranial aneurysm	5.5e-05	0.000647	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MMP9—intracranial aneurysm	5.35e-05	0.00063	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NOS3—intracranial aneurysm	5.26e-05	0.000619	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—NOS3—intracranial aneurysm	5.24e-05	0.000617	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—NOS3—intracranial aneurysm	5.24e-05	0.000617	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—NOS3—intracranial aneurysm	4.96e-05	0.000583	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NOS3—intracranial aneurysm	4.91e-05	0.000577	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—NOS3—intracranial aneurysm	4.57e-05	0.000537	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—NOS3—intracranial aneurysm	4.26e-05	0.000501	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—NOS3—intracranial aneurysm	4.26e-05	0.000501	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MMP9—intracranial aneurysm	4.22e-05	0.000497	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—NOS3—intracranial aneurysm	4.11e-05	0.000483	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—NOS3—intracranial aneurysm	3.9e-05	0.000459	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—NOS3—intracranial aneurysm	3.47e-05	0.000409	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOS3—intracranial aneurysm	3.29e-05	0.000387	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—NOS3—intracranial aneurysm	2.76e-05	0.000324	CbGpPWpGaD
Indomethacin—ALB—Metabolism—NOS3—intracranial aneurysm	2.23e-05	0.000262	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NOS3—intracranial aneurysm	2e-05	0.000236	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NOS3—intracranial aneurysm	1.95e-05	0.00023	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NOS3—intracranial aneurysm	1.83e-05	0.000215	CbGpPWpGaD
